|
1
|
Folkman J: Angiogenesis: an organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung AS, Lee J and Ferrara N: Targeting
the tumour vasculature: insights from physiological angiogenesis.
Nat Rev Cancer. 10:505–514. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ebos JM and Kerbel RS: Antiangiogenic
therapy: impact on invasion, disease progression, and metastasis.
Nat Rev Clin Oncol. 8:210–221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong ML, Prawira A, Kaye AH and Hovens CM:
Tumour angiogenesis: its mechanism and therapeutic implications in
malignant gliomas. J Clin Neurosci. 16:1119–1130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brower V: Tumor angiogenesis - new drugs
on the block. Nat Biotechnol. 17:963–968. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Teicher BA: Antiangiogenic agents and
targets: a perspective. Biochem Pharmacol. 81:6–12. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Conley SJ, Gheordunescu E, Kakarala P,
Newman B, Korkaya H, Heath AN, et al: Antiangiogenic agents
increase breast cancer stem cells via the generation of tumor
hypoxia. Proc Natl Acad Sci USA. 109:2784–2789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu HY, Pan YM, Chen ZW, Lin Y, Wang LH,
Chen YH, et al: 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced
angiogenesis via suppression of VEGFR-2-signaling pathway. J
Ethnopharmacol. 146:724–733. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao X, Zhou X, Mak NK and Leung KN:
Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated
ERK1/2 signalling pathway. PLoS One. 8:e822942013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Holzer TR, Fulford AD, Nedderman DM,
Umberger TS, Hozak RR, Joshi A, et al: Tumor cell expression of
vascular endothelial growth factor receptor 2 is an adverse
prognostic factor in patients with squamous cell carcinoma of the
lung. PLoS One. 8:e802922013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lynn KD, Udugamasooriya DG, Roland CL,
Castrillon DH, Kodadek TJ and Brekken RA: GU81, a VEGFR2 antagonist
peptoid, enhances the anti-tumor activity of doxorubicin in the
murine MMTV-PyMT transgenic model of breast cancer. BMC Cancer.
10:3972010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Soda Y, Marumoto T, Friedmann-Morvinski D,
Soda M, Liu F, Michiue H, et al: Transdifferentiation of
glioblastoma cells into vascular endothelial cells. Proc Natl Acad
Sci USA. 108:4274–4280. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hutchinson E: Stem cells: tumour stem
cells generate vasculature. Nat Rev Cancer. 11:42011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ricci-Vitiani L, Pallini R, Biffoni M,
Todaro M, Invernici G, Cenci T, et al: Tumour vascularization via
endothelial differentiation of glioblastoma stem-like cells.
Nature. 468:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamerlik P, Lathia JD, Rasmussen R, Wu Q,
Bartkova J, Lee M, et al: Autocrine VEGF-VEGFR2-Neuropilin-1
signaling promotes glioma stem-like cell viability and tumor
growth. J Exp Med. 209:507–520. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calabrese C, Poppleton H, Kocak M, Hogg
TL, Fuller C, Hamner B, et al: A perivascular niche for brain tumor
stem cells. Cancer Cell. 11:69–82. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saraswati S and Agrawal SS: Brucine, an
indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced
angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and
in vivo. Cancer Lett. 332:83–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang G, Panigrahy D, Mahakian LM, Yang J,
Liu JY, Stephen Lee KS, et al: Epoxy metabolites of docosahexaenoic
acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc
Natl Acad Sci USA. 110:6530–6535. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang R, Chadalavada K, Wilshire J, Kowalik
U, Hovinga KE, Geber A, et al: Glioblastoma stem-like cells give
rise to tumour endothelium. Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew
D, et al: Morelloflavone, a biflavonoid, inhibits tumor
angiogenesis by targeting rho GTPases and extracellular
signal-regulated kinase signaling pathways. Cancer Res. 69:518–525.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adini A, Fainaru O, Udagawa T, Connor KM,
Folkman J and D’Amato RJ: Matrigel cytometry: a novel method for
quantifying angiogenesis in vivo. J Immunol Methods. 342:78–81.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao Z, Zheng J, Yang B, Wang Z, Fan H, Lv
Y, et al: Sonodynamic therapy inhibits angiogenesis and tumor
growth in a xenograft mouse model. Cancer Lett. 335:93–99. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Evellin S, Galvagni F, Zippo A, Neri F,
Orlandini M, Incarnato D, et al: FOSL1 controls the assembly of
endothelial cells into capillary tubes by direct repression of αv
and β3 integrin transcription. Mol Cell Biol. 33:1198–1209.
2013.PubMed/NCBI
|
|
25
|
Scully S, Francescone R, Faibish M,
Bentley B, Taylor SL, Oh D, et al: Transdifferentiation of
glioblastoma stem-like cells into mural cells drives vasculogenic
mimicry in glioblastomas. J Neurosci. 32:12950–12960. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng L, Huang Z, Zhou W, Wu Q, Donnola S,
Liu JK, et al: Glioblastoma stem cells generate vascular pericytes
to support vessel function and tumor growth. Cell. 153:139–152.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dong J, Zhao Y, Huang Q, Fei X, Diao Y,
Shen Y, et al: Glioma stem/progenitor cells contribute to
neovascularization via transdifferentiation. Stem Cell Rev.
7:141–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ribatti D: Cancer stem cells and tumor
angiogenesis. Cancer Lett. 321:13–17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bao S, Wu Q, Sathornsumetee S, Hao Y, Li
Z, Hjelmeland AB, et al: Stem cell-like glioma cells promote tumor
angiogenesis through vascular endothelial growth factor. Cancer
Res. 66:7843–7848. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chanthery YH, Gustafson WC, Itsara M,
Persson A, Hackett CS, Grimmer M, et al: Paracrine signaling
through MYCN enhances tumor-vascular interactions in neuroblastoma.
Sci Transl Med. 4:115ra32012.PubMed/NCBI
|
|
31
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Potente M, Gerhardt H and Carmeliet P:
Basic and therapeutic aspects of angiogenesis. Cell. 146:873–887.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: mechanisms of anti-tumour activity. Nat Rev Cancer.
8:579–591. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Goel HL and Mercurio AM: VEGF targets the
tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chatterjee S, Heukamp LC, Siobal M,
Schttle J, Wieczorek C, Peifer M, et al: Tumor VEGF: VEGFR2
autocrine feed-forward loop triggers angiogenesis in lung cancer. J
Clin Invest. 123:1732–1740. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao D, Nolan DJ, Mellick AS, Bambino K,
McDonnell K and Mittal V: Endothelial progenitor cells control the
angiogenic switch in mouse lung metastasis. Science. 319:195–198.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang YH, Yuan JP, Righi E, Kamoun WS,
Ancukiewicz M, Nezivar J, et al: Vascular normalizing doses of
antiangiogenic treatment reprogram the immunosuppressive tumor
microenvironment and enhance immunotherapy. Proc Natl Acad Sci USA.
109:17561–17566. 2012. View Article : Google Scholar
|
|
38
|
Spring H, Schuler T, Arnold B, Hammerling
GJ and Ganss R: Chemokines direct endothelial progenitors into
tumor neovessels. Proc Natl Acad Sci USA. 102:18111–18116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Narunsky L, Oren R, Bochner F and Neeman
M: Imaging aspects of the tumor stroma with therapeutic
implications. Pharmacol Ther. 141:192–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang X: Tumor-associated macrophages as
potential diagnostic and prognostic biomarkers in breast cancer.
Cancer Lett. 332:3–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
